Cloud P. Paweletz

2000–2025 年に発表

108
論文数
20,781
被引用数
71
h 指数
104
i10 指数

被引用数

Cloud P. Paweletz の年別被引用数2000 年: 被引用 12 件2001 年: 被引用 31 件2002 年: 被引用 86 件2003 年: 被引用 96 件2004 年: 被引用 121 件2005 年: 被引用 99 件2006 年: 被引用 84 件2007 年: 被引用 63 件2008 年: 被引用 55 件2009 年: 被引用 38 件2010 年: 被引用 68 件2011 年: 被引用 53 件2012 年: 被引用 44 件2013 年: 被引用 41 件2014 年: 被引用 50 件2015 年: 被引用 71 件2016 年: 被引用 172 件2017 年: 被引用 222 件2018 年: 被引用 291 件2019 年: 被引用 932 件2020 年: 被引用 1,113 件2021 年: 被引用 1,286 件2022 年: 被引用 1,070 件2023 年: 被引用 902 件2024 年: 被引用 1,365 件2025 年: 被引用 789 件2026 年: 被引用 24 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,560 件、この内訳の 29.3%中国: 引用元論文 1,803 件、この内訳の 14.9%イギリス: 引用元論文 585 件、この内訳の 4.8%イタリア: 引用元論文 572 件、この内訳の 4.7%ドイツ: 引用元論文 541 件、この内訳の 4.5%フランス: 引用元論文 474 件、この内訳の 3.9%日本: 引用元論文 426 件、この内訳の 3.5%スペイン: 引用元論文 376 件、この内訳の 3.1%オーストラリア: 引用元論文 317 件、この内訳の 2.6%カナダ: 引用元論文 303 件、この内訳の 2.5%オランダ: 引用元論文 295 件、この内訳の 2.4%韓国: 引用元論文 288 件、この内訳の 2.4%
0%29.3%その他 21.4%

分野

  • Medicine49.6%
  • Biochemistry, Genetics and Molecular Biology32.8%
  • Immunology and Microbiology11.1%
  • Chemistry2.8%
  • Engineering2%
  • Agricultural and Biological Sciences0.3%
  • その他1.4%

トピック

  • Lung Cancer Treatments and Mutations7.3%
  • Cancer Genomics and Diagnostics6.9%
  • Cancer Immunotherapy and Biomarkers6.6%
  • CAR-T cell therapy research3.1%
  • Immunotherapy and Immune Responses3%
  • Immune Cell Function and Interaction2.9%
  • その他70.2%

共著者

全論文

検索で開く
  1. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer A. Wargo, Genevieve M. Boland, Ryan J. Sullivan, Gad Getz, Nir Hacohen - Cell 2018 被引用: 2,103

  2. Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C

    著者: , , , , , , , , , , , , , , - New England Journal of Medicine 2022 被引用: 485

  3. Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rameen Beroukhim, Pratiti Bandopadhayay, Mark M. Awad, Prafulla C. Gokhale, Paul T. Kirschmeier, Jarrod A. Marto, Fernando D. Camargo, Rizwan Haq, Cloud P. Paweletz, Kwok‐Kin Wong, David A. Barbie, Henry W. Long, Nathanael S. Gray, Pasi A. Jänne - Cancer Cell 2020 被引用: 472

  4. Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

    著者: , , , , , , , , , , , , , , , - Nature Medicine 2015 被引用: 1,539

  5. Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lauren Keogh, María Anguiano, Lance Stapleton, Zhiheng Jia, Michal Barzily-Rokni, Israel Cañadas, Tran C. Thai, Marc R. Hammond, Raven Vlahos, Eric S. Wang, Hua Zhang, Shuai Li, Glenn J. Hanna, Wei Huang, Mai P. Hoang, Adriano Piris, Jean-Pierre Eliane, Anat Stemmer‐Rachamimov, Lisa Cameron, Mei-Ju Su, Parin Shah, Benjamin Izar, Manisha Thakuria, Nicole R. LeBoeuf, Guilherme Rabinowits, Viswanath Gunda, Sareh Parangi, James M. Cleary, Brian C. Miller, Shunsuke Kitajima, Rohit Thummalapalli, Benchun Miao, Thanh U. Barbie, Vivek Sivathanu, Joshua A. Wong, William G. Richards, Raphael Bueno, Charles H. Yoon, Juan J. Miret, Meenhard Herlyn, Levi A. Garraway, Eliezer M. Van Allen, Gordon J. Freeman, Paul T. Kirschmeier, Jochen H. Lorch, Patrick A. Ott, F. Stephen Hodi, Keith T. Flaherty, Roger D. Kamm, Genevieve M. Boland, Kwok‐Kin Wong, David Dornan, Cloud P. Paweletz, David A. Barbie - Cancer Discovery 2017 被引用: 585

  6. CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jay C. Strum, William G. Richards, Jochen H. Lorch, Sareh Parangi, Viswanath Gunda, Genevieve M. Boland, Raphael Bueno, Sangeetha Palakurthi, Gordon J. Freeman, Jerome Ritz, W. Nicholas Haining, Norman E. Sharpless, Haribabu Arthanari, Geoffrey I. Shapiro, David A. Barbie, Nathanael S. Gray, Kwok‐Kin Wong - Cancer Discovery 2017 被引用: 781

  7. Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer

    著者: , , , , , , , , , , , , , , , , - Cancer Discovery 2018 被引用: 515

  8. Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xitao Wang, Bowen Chen, Fangxin Hong, Lynette M. Sholl, Michael Tolstorukov, Kathleen L. Pfaff, Pasi A. Jänne, Evisa Gjini, Robin Edwards, Scott J. Rodig, Ellis L. Reinherz, Matthew G. Oser, David A. Barbie - Cancer Discovery 2021 被引用: 214

  9. Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies

    著者: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 435

  10. Targeting TBK1 to overcome resistance to cancer immunotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xingping Qin, Kristopher A. Sarosiek, Gao Zhang, Jong Wook Kim, Mack Y. Su, Angelina M. Cicerchia, Martin Q. Rasmussen, Samuel J. Klempner, Dejan Juric, Sara I. Pai, David M. Miller, Anita Giobbie‐Hurder, Jonathan Chen, Karin Pelka, Dennie T. Frederick, Susanna Stinson, Elena V. Ivanova, Amir Reza Aref, Cloud P. Paweletz, David A. Barbie, Debattama R. Sen, David E. Fisher, Ryan B. Corcoran, Nir Hacohen, Peter K. Sorger, Keith T. Flaherty, Genevieve M. Boland, Robert T. Manguso, Russell W. Jenkins - Nature 2023 被引用: 167

  11. Assessment of Resistance Mechanisms and Clinical Implications in Patients WithEGFRT790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

    著者: , , , , , , , , , , , , , , - JAMA Oncology 2018 被引用: 689

  12. Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jessica Ley, Luc G.T. Morris, Lara Dunn, Cloud P. Paweletz, Dorina Kallogjeri, Jay F. Piccirillo, Douglas R. Adkins, Catherine J. Wu, Ravindra Uppaluri - Science Immunology 2023 被引用: 116

  13. Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lynnette Marie Sholl, Ewa Sicińska, Jacob Sands, Scott J. Rodig, Kwok‐Kin Wong, Cloud P. Paweletz, Hideo Watanabe, David A. Barbie - Nature Medicine 2018 被引用: 317

  14. TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2024 被引用: 94

  15. False-Positive Plasma Genotyping Due to Clonal Hematopoiesis

    著者: , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 446

  16. Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2020 被引用: 174

  17. MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2022 被引用: 101

  18. 3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , - Lab on a Chip 2018 被引用: 251

  19. Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLC

    著者: , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 被引用: 219

  20. Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC

    著者: , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2020 被引用: 158

  21. Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 被引用: 103

  22. Activation of Tumor-Cell STING Primes NK-Cell Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pınar Ö. Eser, Zehua Li, Israel Cañadas, Marina Vivero, Assunta De Rienzo, William G. Richards, Adnan O. Abu‐Yousif, Vicky A. Appleman, Richard C. Gregory, Alexander Parent, Neil Lineberry, Eric L. Smith, Pasi A. Jänne, Juan J. Miret, Michael Tolstorukov, Rizwan Romee, Cloud P. Paweletz, Raphael Bueno, David A. Barbie - Cancer Immunology Research 2022 被引用: 88

  23. Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer

    著者: , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 843

  24. EGFR Inhibition Enhances the Cellular Uptake and Antitumor-Activity of the HER3 Antibody–Drug Conjugate HER3–DXd

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2021 被引用: 71